---
schema_version: "secwatch.filing_event.v1"
accession: "0001079973-24-001502"
form_type: "8-K"
ticker: "LCTC"
cik: "0001493137"
company_name: "Lifeloc Technologies, Inc"
filed_at: "2024-11-12T23:59:59+00:00"
generated_at: "2026-05-30T01:47:25.903445+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Lifeloc Q3 2024 net loss $158K, revenue down 23% YoY; SpinDx progress

## Summary
- Q3 net revenue $2.087M (down 23% YoY); net loss $158K ($0.06/diluted) vs prior year profit $110K.
- Nine-month 2024 revenue $6.628M, net loss $740K ($0.30/diluted) vs prior year profit $111K.
- Gross margin improved to 43.7% in Q3 vs 41.5% last year; nine-month 41.4% vs 43.4%.
- SpinDx saliva THC detection system beta testing planned this quarter; commercial launch projected later in 2025.
- Raised $750K line of credit and $798K private placement (210K shares at $3.80) to fund SpinDx development.

## SEC filing metadata
- accession: 0001079973-24-001502
- form_type: 8-K
- ticker: LCTC
- cik: 0001493137
- company_name: Lifeloc Technologies, Inc
- filed_at: 2024-11-12T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1493137/000107997324001502/0001079973-24-001502-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1493137/000107997324001502/lctc_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001079973-24-001502
- JSON: https://secwatch.observer/filing/0001079973-24-001502.json
- Plain text: https://secwatch.observer/filing/0001079973-24-001502.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.